NCT01275469 - Pilot Study With GFT505 (80mg) in Patients Presenting With Impaired Glucose Tolerance and Abdominal Obesity. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions

Impaired Glucose ToleranceAbdominal Obesity

Interventions

DRUG

GFT505 80mg

Hard gelatin capsules dosed at 20mg, oral administration, 4 capsules per day before breakfast.

DRUG

Placebo

Hard gelatin capsules, oral administration, 4 capsules per day before breakfast.

Trial Locations (20)

44093

Site n°2, Nantes

49000

Site n°31, Angers

Site n°32, Angers

Site n°36, Angers

Site n°37, Angers

49100

Site n°34, Angers

Site n°35, Angers

Site n°39, Angers

49125

Site n°17, Briollay

Site n°30, Tiercé

49300

Site n°16, Cholet

Site n°19, Cholet

49310

Site n°18, Vihiers

49390

Site n°13, Parçay-les-Pins

49410

Site n°14, Le Mesnil-en-Vallée

49500

Site n°15, Segré

49610

Site n°10, Mûrs-Erigné

Site n°12, Mûrs-Erigné

75013

Site n°1, Paris

79100

Site n°11, Thouars